ROYAL BANK OF CANADA - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$15,000
+25.0%
7,149
+81.9%
0.00%
Q2 2023$12,000
+100.0%
3,931
+369.1%
0.00%
Q4 2022$6,0000.0%838
-46.7%
0.00%
Q3 2022$6,000
-14.3%
1,572
+34.8%
0.00%
Q1 2022$7,000
-84.1%
1,166
-69.5%
0.00%
Q4 2021$44,000
+46.7%
3,817
+100.7%
0.00%
Q3 2021$30,000
+100.0%
1,902
+143.5%
0.00%
Q2 2021$15,000
-67.4%
781
-27.6%
0.00%
Q1 2021$46,0001,0780.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$38,425,0008.39%
OUP Management Co., LLC 374,714$2,263,0001.72%
RA Capital Management 11,120,973$67,171,0001.47%
Paradigm Biocapital Advisors LP 894,404$5,402,0001.43%
JOHNSON & JOHNSON 1,074,658$6,491,0001.23%
Sarissa Capital Management LP 707,010$4,270,0000.40%
Artal Group S.A. 550,000$3,322,0000.14%
Woodline Partners LP 1,111,123$6,711,0000.11%
Orbimed Advisors 833,333$5,033,0000.08%
Laurion Capital Management LP 857,308$5,178,0000.06%
View complete list of VOR BIOPHARMA INC shareholders